Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Wilson Sonsini said it published an analysis of new and revised SEC staff interpretations addressing equity compensation and benefit-plan registration. The firm’s article examines restricted stock and unit awards, assumed awards held by former employees, registration fees and the calculation of insider-reporting deadlines for transactions on foreign exchanges.
Wilson Sonsini said it advised Amaero on its initial public offering, priced on October 14, 2026. The firm described Amaero as a U.S. producer of metal powders for additive and advanced manufacturing, and said its shares began Nasdaq Capital Market trading the following day under AMRO.
Wilson Sonsini said it advised Iambic Therapeutics on a $150 million initial public offering. The firm described Iambic as a clinical-stage life sciences and technology company using an AI-driven platform, and said its shares began Nasdaq Global Select Market trading on October 15, 2026, under IAM.
Wilson Sonsini said it advised financial technology company Meow on a $31.6 million Series B financing announced on October 15, 2026. The firm said the financing formed part of a broader investment and partnership that will bring Meow’s platform to Stifel’s commercial banking clients.
Wilson Sonsini said it advised Recursion Pharmaceuticals on an underwritten public offering that closed on October 16, 2026. The firm said the clinical-stage company uses AI in drug discovery and development and raised approximately $200 million before underwriting discounts, commissions and estimated expenses.
Wilson Sonsini said Theodore “Ted” Posner joined its Washington, D.C., office as a partner from Baker Botts. The firm said he brings more than 30 years of government and private-practice experience advising on foreign investment reviews, international trade and cross-border regulatory matters.
Wilson Sonsini said Kate Schuelke joined its Executive Advisory Program as an executive advisor based in Palo Alto. The firm said she will advise general counsel, senior executives and boards on legal, governance and business matters, drawing on her experience leading technology company legal teams.
Wilson Sonsini announced that it had advised Circle Pharma on a $92.5 million Series E led by The Column Group. The firm said the financing would support early clinical development of a breast-cancer treatment candidate and further development of the company’s pipeline of cyclin-targeted macrocycle drugs.
Wilson Sonsini announced that it had advised Nex on more than $150 million in new equity and debt financing. The firm said the funding supported the active-play company’s international expansion, broader retail distribution and additional content partnerships following growth in its United States consumer business.
Wilson Sonsini announced that it had advised textile-recycling technology company Ravel on an $8.2 million seed funding round led by One Small Planet. The firm said the financing had closed and would support work toward commercial readiness for the company’s textile-to-textile material recovery technology.